FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Kairos Pharma, Ltd. Stock AnalysisComprehensive stock analysis for Kairos Pharma, Ltd. (KAPA) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisKAPA
KAPA
Kairos Pharma, Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KAPA
Home🔹Stocks🔹Kairos Pharma, Ltd.

Kairos Pharma, Ltd.

KAPA•AMEX

Kairos Pharma, Ltd.

KAPA•AMEX
Market cap
$6.50M
Sentiment

Your view on KAPA

Mkt Cap
$6.50M
Sentiment
Your view
KAPA
Kairos Pharma, Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KAPA
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Kairos Pharma, Ltd.

Industry
Biotechnology
Sector
Healthcare
CEO
John S. Yu
Headquarters
US
Industry
Biotechnology
Sector
Healthcare
CEO
John S. Yu
Headquarters
US
Description

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News